PETH: Paul Jannetto, Ph.D.
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' new test for alcohol consumption. PETH is a blood direct biomarker test that offers a window of detection of about two to four weeks — compared with five days for urine-based screening for alcohol
Episode 174 of the Answers from the Lab podcast, hosted by Mayo Clinic Laboratories, titled "PETH: Paul Jannetto, Ph.D." was published on September 13, 2022 and runs 10 minutes.
September 13, 2022 ·10m · Answers from the Lab
Summary
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' new test for alcohol consumption. PETH is a blood direct biomarker test that offers a window of detection of about two to four weeks — compared with five days for urine-based screening for alcohol use.
Episode Description
(00:32)
Would you mind sharing a bit about yourself and your background?
(01:44)
Would it be fair to say you're an expert on this topic?
(01:57)
Could you help us understand the role of laboratory testing in supporting recovery from alcohol use disorders, and how to approach testing for those patients?
(04:50)
Could you help us understand our new direct alcohol biomarker test and its benefits?
(07:57)
What other tests are available, and how do they compare with this biomarker?
Similar Episodes
Apr 5, 2026 ·6m
Apr 2, 2026 ·5m
Mar 29, 2026 ·7m
Mar 19, 2026 ·5m
Mar 15, 2026 ·7m
Mar 9, 2026 ·12m